Changyi Quan

763 total citations
32 papers, 592 citations indexed

About

Changyi Quan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Changyi Quan has authored 32 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Changyi Quan's work include Bladder and Urothelial Cancer Treatments (7 papers), Epigenetics and DNA Methylation (5 papers) and Urological Disorders and Treatments (5 papers). Changyi Quan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Epigenetics and DNA Methylation (5 papers) and Urological Disorders and Treatments (5 papers). Changyi Quan collaborates with scholars based in China, South Korea and United States. Changyi Quan's co-authors include Wun‐Jae Kim, Pildu Jeong, Jiyeon Kim, Suk‐Chul Bae, Eun‐Jung Kim, Hyung-Lae Lee, Keon Myung Lee, Eun‐Jong Cha, Suk-Chul Bae and Yoshiaki Ito and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Changyi Quan

29 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changyi Quan China 11 438 152 138 124 96 32 592
Veronica Mason United States 6 355 0.8× 128 0.8× 121 0.9× 90 0.7× 114 1.2× 7 570
Tian Tao China 14 276 0.6× 85 0.6× 99 0.7× 179 1.4× 115 1.2× 45 530
Òscar Reig Spain 13 190 0.4× 303 2.0× 103 0.7× 153 1.2× 218 2.3× 56 562
Hsi Chin Wu Taiwan 11 216 0.5× 203 1.3× 59 0.4× 125 1.0× 130 1.4× 22 502
Hélène Hovington Canada 14 232 0.5× 201 1.3× 180 1.3× 111 0.9× 145 1.5× 34 604
Kelly L. Mueller United States 12 303 0.7× 133 0.9× 182 1.3× 104 0.8× 257 2.7× 14 683
Frances M. Martin United States 8 215 0.5× 158 1.0× 136 1.0× 99 0.8× 162 1.7× 13 460
Morio Sawada Japan 14 304 0.7× 80 0.5× 106 0.8× 106 0.9× 124 1.3× 25 606
Simona Cagiano Italy 9 215 0.5× 120 0.8× 98 0.7× 140 1.1× 123 1.3× 11 485
W. P. Peelen Netherlands 9 150 0.3× 212 1.4× 100 0.7× 85 0.7× 62 0.6× 14 400

Countries citing papers authored by Changyi Quan

Since Specialization
Citations

This map shows the geographic impact of Changyi Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyi Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyi Quan more than expected).

Fields of papers citing papers by Changyi Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyi Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyi Quan. The network helps show where Changyi Quan may publish in the future.

Co-authorship network of co-authors of Changyi Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Changyi Quan. A scholar is included among the top collaborators of Changyi Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyi Quan. Changyi Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, Yujun Xu, Xiaoguang Xu, et al.. (2025). Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma. International Immunopharmacology. 156. 114725–114725. 1 indexed citations
3.
Li, Yajun, et al.. (2024). MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via ERK-AP1-MMPs axis. Scientific Reports. 14(1). 9411–9411. 1 indexed citations
5.
Zhu, Shimiao, Yang Zhao, Zheng Zhang, et al.. (2023). HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell Death and Disease. 14(3). 215–215. 6 indexed citations
6.
Lu, Youyi, et al.. (2023). Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study. Frontiers in Oncology. 13. 1115830–1115830. 5 indexed citations
8.
Wen, Simeng, et al.. (2022). Primary teratoma of the adrenal gland: a case report. Translational Cancer Research. 11(8). 2985–2989.
9.
Quan, Changyi, et al.. (2021). Primary Renal Leiomyosarcoma. Journal of College of Physicians And Surgeons Pakistan. 31(6). 725–727. 2 indexed citations
10.
Wang, Jiang, Xiaoqing Yang, Wenjie Tian, et al.. (2021). Progress in studies on pathological changes and future treatment strategies of obesity-associated female stress urinary incontinence: a narrative review. Translational Andrology and Urology. 10(1). 494–503. 7 indexed citations
11.
Zhou, Xiaodong, et al.. (2020). Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-β1/EMT pathway. Translational Andrology and Urology. 9(3). 1013–1027. 12 indexed citations
12.
Wang, Jiang, Ruili Guan, Wenjie Tian, et al.. (2020). Role and mechanism of micro-energy treatment in regenerative medicine. Translational Andrology and Urology. 9(2). 690–701. 6 indexed citations
13.
Ma, Baojie, Yu Li, Xingkang Jiang, et al.. (2019). Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results. European Journal of Surgical Oncology. 45(10). 1993–1999. 2 indexed citations
14.
Xie, Hui, Gang Li, Kangkang Liu, et al.. (2019). <p>Development and validation of CT imaging–based preoperative nomogram in the prediction of unfavorable high-grade small renal masses</p>. Cancer Management and Research. Volume 11. 8731–8741. 2 indexed citations
15.
Yu, Jianpeng, Libin Sun, Boya Zhang, et al.. (2019). Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer. Annals of Translational Medicine. 7(23). 729–729. 17 indexed citations
16.
Tang, Yang, Minghao Zhang, Zhiqun Shang, et al.. (2013). TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis. Tumor Biology. 35(1). 667–673. 7 indexed citations
17.
Chen, Jing, Shimiao Zhu, Ning Jiang, et al.. (2012). HoxB3 promotes prostate cancer cell progression by transactivating CDCA3. Cancer Letters. 330(2). 217–224. 62 indexed citations
18.
Quan, Changyi, et al.. (2011). Laparoscopic Madigan Prostatectomy. Journal of Endourology. 25(12). 1879–1882. 15 indexed citations
19.
Zhang, Zhihong, Xiaolei Guo, Baojie Ma, et al.. (2009). Prevalence of benign prostate hyperplasia and its relative factors in rural areas of Tianjin in 2008. Zhonghua miniao waike zazhi. 30(11). 761–764. 2 indexed citations
20.
Kim, Eunjung, Pildu Jeong, Changyi Quan, et al.. (2005). Genotypes of TNF-α, VEGF, hOGG1, GSTM1, and GSTT1: Useful determinants for clinical outcome of bladder cancer. Urology. 65(1). 70–75. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026